Met receptor tyrosine kinase signals through a cortactin–Gab1 scaffold complex, to mediate invadopodia

Summary Invasive carcinoma cells form actin-rich matrix-degrading protrusions called invadopodia. These structures resemble podosomes produced by some normal cells and play a crucial role in extracellular matrix remodeling. In cancer, formation of invadopodia is strongly associated with invasive potential. Although deregulated signals from the receptor tyrosine kinase Met (also known as hepatocyte growth factor are linked to cancer metastasis and poor prognosis, its role in invadopodia formation is not known. Here we show that stimulation of breast cancer cells with the ligand for Met, hepatocyte growth factor, promotes invadopodia formation, and in aggressive gastric tumor cells where Met is amplified, invadopodia formation is dependent on Met activity. Using both GRB2-associated-binding protein 1 (Gab1)-null fibroblasts and specific knockdown of Gab1 in tumor cells we show that Met-mediated invadopodia formation and cell invasion requires the scaffold protein Gab1. By a structure–function approach, we demonstrate that two proline-rich motifs (P4/5) within Gab1 are essential for invadopodia formation. We identify the actin regulatory protein, cortactin, as a direct interaction partner for Gab1 and show that a Gab1–cortactin interaction is dependent on the SH3 domain of cortactin and the integrity of the P4/5 region of Gab1. Both cortactin and Gab1 localize to invadopodia rosettes in Met-transformed cells and the specific uncoupling of cortactin from Gab1 abrogates invadopodia biogenesis and cell invasion downstream from the Met receptor tyrosine kinase. Met localizes to invadopodia along with cortactin and promotes phosphorylation of cortactin. These findings provide insights into the molecular mechanisms of invadopodia formation and identify Gab1 as a scaffold protein involved in this process.

[1]  S. Courtneidge,et al.  The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function , 2011, Nature Reviews Molecular Cell Biology.

[2]  Z. Kouchi,et al.  Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation , 2011, The Journal of cell biology.

[3]  Takayuki Kosaka,et al.  Mechanisms of Resistance to EGFR TKIs and Development of a New Generation of Drugs in Non-Small-Cell Lung Cancer , 2011, Journal of biomedicine & biotechnology.

[4]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[5]  Thinzar M. Lwin,et al.  Twist1-induced invadopodia formation promotes tumor metastasis. , 2011, Cancer cell.

[6]  J. Condeelis,et al.  An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. , 2011, Cancer research.

[7]  A. Boggs,et al.  c-Src differentially regulates the functions of microtentacles and invadopodia , 2010, Oncogene.

[8]  S. Weed,et al.  Oncogenic Src requires a wild-type counterpart to regulate invadopodia maturation , 2010, Journal of Cell Science.

[9]  J. Condeelis,et al.  Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia , 2010, Journal of Cell Science.

[10]  I. Pichot,et al.  Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp. , 2010, Cancer research.

[11]  A. Pendergast,et al.  Abl Kinases Are Required for Invadopodia Formation and Chemokine-induced Invasion* , 2010, The Journal of Biological Chemistry.

[12]  H. Yamaguchi,et al.  Membrane lipids in invadopodia and podosomes: Key structures for cancer invasion and metastasis , 2010, Oncotarget.

[13]  B. Blagoev,et al.  PTP1B Targets the Endosomal Sorting Machinery , 2010, The Journal of Biological Chemistry.

[14]  Robert D. Goldman,et al.  Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia , 2010, The Journal of cell biology.

[15]  Kimito Yamada,et al.  Epidermal growth factor‐dependent enhancement of invasiveness of squamous cell carcinoma of the breast , 2010, Cancer science.

[16]  Morag Park,et al.  The Gab1 scaffold regulates RTK-dependent dorsal ruffle formation through the adaptor Nck , 2010, Journal of Cell Science.

[17]  A. Brunati,et al.  Recognition of lysine‐rich peptide ligands by murine cortactin SH3 domain: CD, ITC, and NMR studies , 2009, Biopolymers.

[18]  Morag Park,et al.  Crosstalk in Met receptor oncogenesis. , 2009, Trends in cell biology.

[19]  M. Gimona,et al.  Tks5 recruits AFAP-110, p190RhoGAP, and cortactin for podosome formation. , 2009, Experimental cell research.

[20]  Jacco van Rheenen,et al.  Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation , 2009, The Journal of cell biology.

[21]  R. Cardiff,et al.  Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer , 2009, Proceedings of the National Academy of Sciences.

[22]  S. Stylli,et al.  Nck adaptor proteins link Tks5 to invadopodia actin regulation and ECM degradation , 2009, Journal of Cell Science.

[23]  J. Condeelis,et al.  N-WASP and cortactin are involved in invadopodium-dependent chemotaxis to EGF in breast tumor cells. , 2009, Cell motility and the cytoskeleton.

[24]  T. Takenawa,et al.  PtdIns(3,4)P2 instigates focal adhesions to generate podosomes , 2009, Cell adhesion & migration.

[25]  V. Castronovo,et al.  Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer. , 2009, Cancer research.

[26]  R. Buccione,et al.  Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix , 2009, Cancer and Metastasis Reviews.

[27]  H. Sasaki,et al.  Met gene copy number predicts the prognosis for completely resected non‐small cell lung cancer , 2008, Cancer science.

[28]  I. Pass,et al.  A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo. , 2008, European journal of cell biology.

[29]  Alissa M. Weaver,et al.  A new role for cortactin in invadopodia: regulation of protease secretion. , 2008, European journal of cell biology.

[30]  T. Takenawa,et al.  Sequential signals toward podosome formation in NIH-src cells , 2008, The Journal of cell biology.

[31]  M. Tremblay,et al.  PTP1B Regulates Cortactin Tyrosine Phosphorylation by Targeting Tyr446* , 2008, Journal of Biological Chemistry.

[32]  J. Tuynman,et al.  Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma , 2008, British Journal of Cancer.

[33]  A. Huttenlocher,et al.  Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion , 2008, The Journal of cell biology.

[34]  M. Naujokas,et al.  Gab2 requires membrane targeting and the met binding motif to promote lamellipodia, cell scatter, and epithelial morphogenesis downstream from the met receptor , 2008, Journal of cellular physiology.

[35]  M. Gimona The microfilament system in the formation of invasive adhesions. , 2008, Seminars in cancer biology.

[36]  P. Comoglio,et al.  The MET receptor tyrosine kinase in invasion and metastasis , 2007, Journal of cellular physiology.

[37]  P. Timpson,et al.  Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib. , 2007, Cancer research.

[38]  Alissa M. Weaver,et al.  Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. , 2007, Cancer research.

[39]  M. Weiser,et al.  Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. , 2007, Cancer letters.

[40]  B. Webb,et al.  Dissecting the functional domain requirements of cortactin in invadopodia formation. , 2007, European journal of cell biology.

[41]  S. Linder The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. , 2007, Trends in cell biology.

[42]  M. Park,et al.  From Tpr-Met to Met, tumorigenesis and tubes , 2007, Oncogene.

[43]  E. Kistner,et al.  c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. , 2007, Cancer research.

[44]  Y. Onodera,et al.  CIN85, a Cbl‐interacting protein, is a component of AMAP1‐mediated breast cancer invasion machinery , 2007, The EMBO journal.

[45]  András Kapus,et al.  Cortactin: the gray eminence of the cytoskeleton. , 2006, Physiology.

[46]  Rebecca Slack,et al.  Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. , 2006, Experimental cell research.

[47]  Françoise Seillier-Moiseiwitsch,et al.  Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. , 2006, Cancer research.

[48]  P. Comoglio,et al.  Cancer therapy: can the challenge be MET? , 2005, Trends in molecular medicine.

[49]  E. Lengyel,et al.  C‐Met overexpression in node‐positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu , 2005, International journal of cancer.

[50]  J. Resau,et al.  The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. , 2005, Cancer cell.

[51]  W. Birchmeier,et al.  Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.

[52]  J. Christensen,et al.  A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. , 2003, Cancer research.

[53]  Morag Park,et al.  Grb2-independent Recruitment of Gab1 Requires the C-terminal Lobe and Structural Integrity of the Met Receptor Kinase Domain* , 2003, Journal of Biological Chemistry.

[54]  Marina Holgado-Madruga,et al.  Gab1 Is an Integrator of Cell Death versus Cell Survival Signals in Oxidative Stress , 2003, Molecular and Cellular Biology.

[55]  J. Reis-Filho,et al.  Expression of c-met Tyrosine Kinase Receptor Is Biologically and Prognostically Relevant for Primary Cutaneous Malignant Melanomas , 2003, Oncology.

[56]  C. Maroun,et al.  Distinct recruitment and function of Gab1 and Gab2 in Met receptor-mediated epithelial morphogenesis. , 2002, Molecular biology of the cell.

[57]  D. Schlaepfer,et al.  v-Src SH3-enhanced Interaction with Focal Adhesion Kinase at β1 Integrin-containing Invadopodia Promotes Cell Invasion* , 2002, The Journal of Biological Chemistry.

[58]  M. Naujokas,et al.  Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis , 2002, Oncogene.

[59]  Jie Wu,et al.  Phosphotyrosines 627 and 659 of Gab1 Constitute a Bisphosphoryl Tyrosine-based Activation Motif (BTAM) Conferring Binding and Activation of SHP2* , 2001, The Journal of Biological Chemistry.

[60]  Roger Williams,et al.  Hepatocyte Growth Factor/Scatter Factor-induces phosphorylation of cortactin in A431 cells in a Src kinase-independent manner , 2001, Oncogene.

[61]  Peijun Zhang,et al.  Activation of Arp2/3 complex-mediated actin polymerization by cortactin , 2001, Nature Cell Biology.

[62]  D. Kamikura,et al.  A switch from p130Cas/Crk to Gab1/Crk signaling correlates with anchorage independent growth and JNK activation in cells transformed by the Met receptor oncoprotein , 2000, Oncogene.

[63]  C. Maroun,et al.  The Tyrosine Phosphatase SHP-2 Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase , 2000, Molecular and Cellular Biology.

[64]  M. Naujokas,et al.  Identification of an Atypical Grb2 Carboxyl-terminal SH3 Domain Binding Site in Gab Docking Proteins Reveals Grb2-dependent and -independent Recruitment of Gab1 to Receptor Tyrosine Kinases* , 2000, The Journal of Biological Chemistry.

[65]  W. Birchmeier,et al.  Coupling of Gab1 to C-Met, Grb2, and Shp2 Mediates Biological Responses , 2000, The Journal of cell biology.

[66]  P. Comoglio,et al.  Sustained recruitment of phospholipase C-γ to Gab1 is required for HGF-induced branching tubulogenesis , 2000, Oncogene.

[67]  K. Vuori,et al.  Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1 – Crk signaling complex formation , 1999, Oncogene.

[68]  E. Rimm,et al.  Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma , 1999, Cancer.

[69]  D. Thomas,et al.  An invasion-related complex of cortactin, paxillin and PKCμ associates with invadopodia at sites of extracellular matrix degradation , 1999, Oncogene.

[70]  Morag Park,et al.  The Gab1 PH Domain Is Required for Localization of Gab1 at Sites of Cell-Cell Contact and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase , 1999, Molecular and Cellular Biology.

[71]  C. Chi,et al.  Hepatocyte growth factor and Met/HGF receptors in patients with gastric adenocarcinoma. , 1998, Oncology reports.

[72]  M. Tremblay,et al.  Association of the Multisubstrate Docking Protein Gab1 with the Hepatocyte Growth Factor Receptor Requires a Functional Grb2 Binding Site Involving Tyrosine 1356* , 1997, The Journal of Biological Chemistry.

[73]  D. Kamikura,et al.  Efficient Cellular Transformation by the Met Oncoprotein Requires a Functional Grb2 Binding Site and Correlates with Phosphorylation of the Grb2-associated Proteins, Cbl and Gab1* , 1997, The Journal of Biological Chemistry.

[74]  W. Birchmeier,et al.  Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis , 1996, Nature.

[75]  D. Kamikura,et al.  Branching Tubulogenesis but Not Scatter of Madin-Darby Canine Kidney Cells Requires a Functional Grb2 Binding Site in the Met Receptor Tyrosine Kinase* , 1996, The Journal of Biological Chemistry.

[76]  A. Bardelli,et al.  Specific Uncoupling of GRB2 from the Met Receptor , 1996, The Journal of Biological Chemistry.

[77]  D. Kamikura,et al.  Pathways Downstream of Shc and Grb2 Are Required for Cell Transformation by the Tpr-Met Oncoprotein* , 1996, The Journal of Biological Chemistry.

[78]  A. Sparks,et al.  Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[79]  M. Moran,et al.  Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus. , 1995, Oncogene.

[80]  A. Bardelli,et al.  A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family , 1994, Cell.

[81]  T. Urano,et al.  Expression of hepatocyte growth factor(hgf) and C-met gene in human gastric-cancer cell-lines. , 1993, International journal of oncology.

[82]  M. Naujokas,et al.  Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing , 1991, Molecular and cellular biology.

[83]  W. T. Chen,et al.  Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. , 1989, The Journal of experimental zoology.

[84]  J. Segall,et al.  Molecular mechanisms of invadopodium formation: the role of the N-WASP–Arp2/3 complex pathway and cofilin , 2005 .